Market Place
Sourcing Support
All News #Library
Biotech
Accord Biopharma`s Hercessi Receives Preferred Status
05 Jan 2026 //
PR NEWSWIRE
Accord Biopharma Adds IMULDOSA To Express Scripts Formularies
01 Dec 2025 //
PR NEWSWIRE
Accord Biopharma Gets FDA Nod For Denosumab Biosimilars Osvyrti
20 Nov 2025 //
PR NEWSWIRE
Accord Bio Pharma Launches Imuldosa Prefilled Syringes at Lowest
18 Aug 2025 //
PR NEWSWIRE
Bio-Thera Signs Licensing Deal with Intas Pharma for BAT2506
10 Feb 2025 //
PR NEWSWIRE
Accord BioPharma`s HERCESSI 420mg Receives FDA Approval for HER2 Cancers
18 Sep 2024 //
PR NEWSWIRE
Accord BioPharma’s HERCESSI secures FDA approval
30 Apr 2024 //
PHARMACEUTICAL TECHNOLOGY
FDA Approves Accord`s HERCESSI™, Herceptin® Biosimilar
29 Apr 2024 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.